Scout — literature reconnaissance
Type any drug — on or off our catalog — or drop in a clinical trial (an NCT id or a title) and Scout fans out to live PubMed and the openFDA FAERS pharmacovigilance database to draft a theoretical renal signature and a real-time acute-kidney-injury reporting signal — with every article it rests on.
Experimental — hypothesis-generating only. Scout drafts a theoretical renal signature from an automated PubMed review and a live FAERS reporting-odds-ratio. It is not medical advice, not a validated catalog entry, and may be wrong. Verify every claim against primary literature.
How it works
Three request-time lookups from a free-text query to a cited, degradation-tolerant draft.
Auto-research the literature
The drug name is translated into a structured PubMed nephrotoxicity query. Scout pulls the result count and the most relevant articles, then drafts a theoretical injury signature grounded in those titles — never inventing a citation.
Live FAERS signal
In parallel, Scout computes an acute-kidney-injury reporting-odds-ratio against the openFDA FAERS API — the same 2×2 recipe as our committed data — and flags a signal only when the 95% CI lower bound clears 1.
Trial fan-out
Give Scout an NCT id or a trial title and it resolves the study's drug interventions on ClinicalTrials.gov, then scouts each arm as its own card. Every upstream degrades gracefully — a sparse or unreachable source simply drops out.
- · The drafted signature is a hypothesis from titles and basic pharmacology — not a reviewed catalog entry. Absence of a PubMed signal for a new agent often reflects how new it is, not its safety.
- · FAERS is a spontaneous reporting system: the ROR measures reporting disproportionality, confounded by indication and notoriety, not incidence or proven causation.
- · Trial resolution only covers registered interventional studies, and a multi-arm study is capped so it can’t spawn unbounded lookups.
- · It generates leads to investigate — it does not establish causation or guide individual patient care.
Scout is an experimental, hypothesis-generating research aid built on automated PubMed review and live pharmacovigilance signals. Its output can be incomplete or wrong. It is not a diagnostic device, not a substitute for clinical judgement, and must not be used to make decisions about real patients. Always verify against primary literature and qualified clinicians.